<DOC>
	<DOCNO>NCT00198159</DOCNO>
	<brief_summary>This study evaluate use ZD1839 treatment subject refractory germ cell tumor . Subjects take ZD1839 one year absence excessive toxicity decision withdraw .</brief_summary>
	<brief_title>A Phase II Study Iressa Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR</brief_title>
	<detailed_description>The primary objective determine response rate ZD1839 patient refractory germ cell tumor express EGFR . The secondary objective determine duration response , time progression overall survival patient refractory germ cell tumor express EGFR treat ZD1839 ; evaluate tolerability ZD1839 patient refractory germ cell tumor correlate tumor response degree EGFR expression immunohistochemistry .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Histologic serologic proof metastatic germ cell neoplasm ( gonadal extragonadal primary ) disease amenable cure either surgery chemotherapy . Patients w/ seminoma nonseminoma eligible , woman w/ ovarian germ cell tumor . Evidence recurrent metastatic carcinoma Must receive initial cisplatin combination therapy &amp; demonstrate progression follow administration least one `` salvage '' regimen advance germ cell neoplasm . Patients eligible first line platinum bsed chemotherapy disease relapse primary mediastinal non seminomatous germ cell tumor , late relapse progress w/in 4 wks last platinum dose . immunohistochemical documentation EGFR expression document . adequate organ function : ANC &gt; /=150 , plt &gt; 100K , total bili &lt; /= upper limit normal ( ULN ) . Pts w/ liver mets 3x ULN.Transaminases 1.5 x ULN alk phos &lt; /=ULN alk phos may 4x ULN transaminase &lt; /= ULN . Pts w/ liver mets may alk phos 5x ULN . Serum crt &lt; /= 2.0 . ECOG performance status 02 . Must 3 week post major surgery , radiotherapy , chemotherapy hae recover toxicity . Active unresolved infection and/or receive concurrent treatment parenteral antibiotic ineligible . Patients require steroid symptomatic brain metastasis eligible . Pregnant lactate patient eligible . Class III/IV heart disease</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Refractory Germ Cell Tumors</keyword>
	<keyword>Germ Cell Tumors</keyword>
</DOC>